Why Does “Environmental Justice” Only Matter for U.S. Solar, Not SE Asian?
The White House says more solar imports will help spread environmental justice in the U.S. Is Southeast Asia our new Environmental Justice League?
Following Solar Debacle, Republicans Come Out Swinging on China
The Republican-led China Task Force held an impromptu meeting Wednesday, where they backed stronger export and capital controls if they win back the House.
U.S. Trade Deficit Eases in April, Down 19.1% to $87.1 Billion
The trade deficit fell. But the January-April goods deficit is still another record breaker.
Biden Just Went Against His Voters, Sided with China on Solar
Voters support locally made solar. So why is the Biden administration giving China companies under investigation for trade violations in SE Asia duty-free access to the U.S.?
FDA’s Updated Drug Shortage List Loaded with Critical Medicines
The Food and Drug Administration recently updated its drug shortage list. More than half of the updates include drugs on the essential medicines list.
Senate Puts FDA Re-authorization Deal in Jeopardy Over Infant Formula Crisis
Senator Burr warned the FDA that until the Senate is okay with their response to the infant formula crisis, and present a plan to prevent it in the future, the Generic Drug User Fee Authorization bill might be put on hold.
How Trade Remedies Helped U.S. Manufacturers
Solar and steel tariffs helped the industry expand. Here is where the naysayers were wrong about rising prices and market destruction due to anti-dumping charges and other trade remedies.
Pharma and Trade Deals Top of Mind in China Commission Hearing
The U.S. China Economic and Security Review Commission discussed the tight-linked China-India pharmaceutical supply chain, and tossed aside the notion that sweeping trade deals with India and the region are good ideas.
Senate Intelligence Hearing on China: “Run Faster and Slow Them Down.”
The Senate Intelligence Committee discusses China’s strategy for economic and technological dominance. Senator Marco Rubio wonders if China will hold supply chains hostage.
FDA Funding Bill Heads to Final Committee, With One Major Stumbling Block
The Health subcommittee of the House Energy and Commerce Committee have moved the FDA user-fee reauthorization bill to final committee. Chairwoman Eshoo says it is on track for September approval.
